Foscarnet for suppression of human immunodeficiency virus replication

C. V. Fletcher; A. C. Collier; F. S. Rhame; D. Bennett; M. F. Para; C. C. Beatty; C. E. Jones; H. H. Balfour

doi:10.1128/AAC.38.3.604

Foscarnet for suppression of human immunodeficiency virus replication

C. V. Fletcher, A. C. Collier, F. S. Rhame, D. Bennett, M. F. Para, C. C. Beatty, C. E. Jones, H. H. Balfour

Laboratory Medicine and Pathology

Research output: Contribution to journal › Comment/debate › peer-review

31 Scopus citations

Abstract

The effect of foscarnet against human immunodeficiency virus (HIV) was evaluated in nine HIV-infected individuals; six completed 28 days of induction therapy. The overall mean increase in CD4⁺ lymphocytes was 64 cells per mm³. The mean decline in the HIV antigen concentration was 108 pg/ml (P = 0.03), and suppression was related to systemic foscarnet exposure by a maximum-effect pharmacodynamic model.

Original language	English (US)
Pages (from-to)	604-607
Number of pages	4
Journal	Antimicrobial agents and chemotherapy
Volume	38
Issue number	3
DOIs	https://doi.org/10.1128/AAC.38.3.604
State	Published - 1994

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1128/AAC.38.3.604

OpenUrl availability

Full text

Cite this

@article{4a3cec65c9fb499e889b62baeca2ca22,

title = "Foscarnet for suppression of human immunodeficiency virus replication",

abstract = "The effect of foscarnet against human immunodeficiency virus (HIV) was evaluated in nine HIV-infected individuals; six completed 28 days of induction therapy. The overall mean increase in CD4+ lymphocytes was 64 cells per mm3. The mean decline in the HIV antigen concentration was 108 pg/ml (P = 0.03), and suppression was related to systemic foscarnet exposure by a maximum-effect pharmacodynamic model.",

author = "Fletcher, {C. V.} and Collier, {A. C.} and Rhame, {F. S.} and D. Bennett and Para, {M. F.} and Beatty, {C. C.} and Jones, {C. E.} and Balfour, {H. H.}",

year = "1994",

doi = "10.1128/AAC.38.3.604",

language = "English (US)",

volume = "38",

pages = "604--607",

journal = "Antimicrobial agents and chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "3",

}

TY - JOUR

T1 - Foscarnet for suppression of human immunodeficiency virus replication

AU - Fletcher, C. V.

AU - Collier, A. C.

AU - Rhame, F. S.

AU - Bennett, D.

AU - Para, M. F.

AU - Beatty, C. C.

AU - Jones, C. E.

AU - Balfour, H. H.

PY - 1994

Y1 - 1994

N2 - The effect of foscarnet against human immunodeficiency virus (HIV) was evaluated in nine HIV-infected individuals; six completed 28 days of induction therapy. The overall mean increase in CD4+ lymphocytes was 64 cells per mm3. The mean decline in the HIV antigen concentration was 108 pg/ml (P = 0.03), and suppression was related to systemic foscarnet exposure by a maximum-effect pharmacodynamic model.

AB - The effect of foscarnet against human immunodeficiency virus (HIV) was evaluated in nine HIV-infected individuals; six completed 28 days of induction therapy. The overall mean increase in CD4+ lymphocytes was 64 cells per mm3. The mean decline in the HIV antigen concentration was 108 pg/ml (P = 0.03), and suppression was related to systemic foscarnet exposure by a maximum-effect pharmacodynamic model.

UR - http://www.scopus.com/inward/record.url?scp=0028289347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028289347&partnerID=8YFLogxK

U2 - 10.1128/AAC.38.3.604

DO - 10.1128/AAC.38.3.604

M3 - Comment/debate

C2 - 7911290

AN - SCOPUS:0028289347

SN - 0066-4804

VL - 38

SP - 604

EP - 607

JO - Antimicrobial agents and chemotherapy

JF - Antimicrobial agents and chemotherapy

IS - 3

ER -

Foscarnet for suppression of human immunodeficiency virus replication

Abstract

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this